ABSTRACT TOPICS

The XVII International DALM Symposium on Diabetes, Obesity, and the Metabolic Syndrome is now accepting abstracts on the following topics:

• Bariatric surgery
• Biomarkers
• Epidemiology
• Genetic Dyslipidemias
• Genetics of CVD, Obesity, and Diabetes
• Guidelines/best clinical practice
• How and when to treat
• How to identify metabolic syndrome
• Hypertension
• Inflammation, Atherosclerosis, and Vascular Biology: Experimental and Human Studies
• Lifestyle: Diet
• Lifestyle: Exercise
• Lifestyle: Integrated Approaches
• New Pharmacological Approaches
• Pharmacotherapy: Anti-thrombotic and Anti-coagulant therapies
• Pharmacotherapy: Diabetes
• Pharmacotherapy: Lipids
• Pharmacotherapy: Obesity
• Special Populations: Elderly people
• Special Populations: Women
• Special Populations: Young people
• Stratification/population parameters
• Whom to treat

SUBMISSION DEADLINE

All Abstracts and Disclosures are due on or before: December 13, 2010 11:59 PM EST.

EVALUATION METHOD

Evaluation of abstracts by a special Abstract Review Committee will be based on the following considerations:

• Originality (idea) – Is the idea truly different or is it a restatement of other work?
• Methods – What was done with the idea? Were the methods described? How reliable and valid are the methods used? Were new or untried methods validated and calibrated properly?
• Analysis – What was done with the data once they were obtained? Were statistical methods used, if necessary, and were they appropriate?
• Results – How reliable were the results? Were they believable? How well were they described?
• Conclusion – Were any conclusions drawn? Were the conclusions appropriate to the questions asked and to the results? Were the conclusions valid?
• Writing – Is the style grammatically correct and is the paper presented in a well-organized, clear and understandable fashion?

The best abstracts will be selected as oral presentations. All other accepted abstracts will be presented as posters.

Notification of acceptance will be by January 18, 2011.